Home

Welcome to MSD

MSD in Malaysia is ultimately owned by Merck & Co., Inc., with headquarters in the U.S.A. Merck & Co., Inc. is a global healthcare leader that discovers, develops, manufactures and markets a broad range of innovative healthcare products. Outside of U.S.A., Merck & Co., Inc. is known as MSD. We have presence in more than 140 countries worldwide. In Malaysia, our headquarters is located in Petaling Jaya and we have 7 branches nationwide. With more than 300 qualified staff, we aim to anticipate the needs of patients and healthcare professionals through smart collaborations that advance healthcare.

LEARN MORE

Our Responsibility

At MSD, we place importance to ethics and integrity. We also see that behaving ethically and with integrity is the responsibility of everyone, every day and in everything we do.

LEARN MORE

Our Focus

MSD is now a leader in a broad range of areas, including cardiology, infectious diseases, diabetes, respiratory, vaccines, women's health, and animal health, and we are also expanding our offerings in other areas, such as neurology, oncology and dermatology.

LEARN MORE

Our employer of Choice

MSD strives to be one of the nation's best employers and most admired companies. Our achievement comes from the importance we place in fulfilling our mission and values, as well as creating an environment that fosters growth and development.

LEARN MORE

Forward-Looking Statement

Forward-Looking Statement of MSD & Co., Inc., Kenilworth, NJ, USA

This website of MSD & Co., Inc., Kenilworth, NJ, USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include, but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and healthcare legislation in the United States and internationally; global trends toward healthcare cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2015 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).

No Duty to Update

The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.